Author:
Herrera-Martínez Aura D.,Gahete Manuel D.,Pedraza-Arevalo Sergio,Sánchez-Sánchez Rafael,Ortega-Salas Rosa,Serrano-Blanch Raquel,Luque Raúl M.,Gálvez-Moreno María A.,Castaño Justo P.
Funder
Instituto de Salud Carlos III
MINECO
Agencia de Innovación y Desarrollo de Andalucía
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference70 articles.
1. A. Dasari et al., Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3(10), 1335–1342 (2017)
2. V.L. Tsikitis, B.C. Wertheim, M.A. Guerrero, Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a SEER analysis. J. Cancer 3, 292–302 (2012)
3. S. Massironi, D. Conte, R.E. Rossi, Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules. Scand J. Gastroenterol. 51(5), 513–523 (2016)
4. I.M. Modlin, K.D. Lye, M. Kidd, A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4), 934–959 (2003)
5. R. Garcia-Carbonero et al., SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014. Clin. Transl. Oncol. 16(12), 1025–1034 (2014)
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献